Specialty Chemicals & Gases

Shree Ganesh Remedies

SGRLBSEMicro Cap

Specialty chemicals and intermediates with niche electronics chemistry potential.

Market Cap

₹950 cr

Price

940

1Y 24%

Direct exposure

30/100

0–100 directness

Hold / Watchlist

Fundamental

61/ 100

Quality of growth, returns, cash conversion and balance sheet

Technical (TQ-100)

80/ 100

Trend, momentum, volume and relative strength composite

Valuation

50/ 100

Higher = cheaper vs peers and own history

Final composite

60/ 100

Blended decision input

Data transparency

What's real, what's pending, on this page

Real financials loaded

✓ Real / verified

· Live price, day change, market cap — NSE direct
· 1Y OHLCV, RSI(14), 50/200 DMA, 1M/3M/1Y returns, RS vs Nifty — computed from real NSE OHLCV
· Sector P/E — NSE direct
· Promoter %, pledge %, MF/FII/public split, 9-quarter history — Trendlyne
· Earnings call AI summaries — Trendlyne (where available)
· Technical (TQ-100) score — computed from real OHLCV
· Annual revenue / EBITDA / PAT / OCF / FCF / equity / assets — Trendlyne (audited annuals)

⚠ Analyst-set (qualitative)

· Segment classification + semicon directness score — analyst seed
· Bull/bear case + monitorables (curated thesis) — analyst seed
· Governance risk score (seed) — being replaced by AI-agent assessment
· Synthesized 5Y forecast removed entirely (was inaccurate)

Real financials extracted for 42 of 45 companies. See /data-sources for full provenance.

Shree Ganesh Remedies · SGRL

₹940-48.94% over 6M

Price50 DMA200 DMA

RSI (14)

Momentum oscillator · 6M view

Volume (60D)

Fundamental score (SageOne 100)

61/ 100B

Growth 20 / Margin 15 / ROC 20 / Cash 15 / Leverage 10 / Reinvestment 8 / Accounting 7 / Governance 5 minus red flags (capped -20).

Base 65

Red flags -4

Growth quality/ 20

0.5

Rev 1Y -12.9% · 3Y CAGR 14.5%

Margin & profitability/ 15

15.0

EBITDA 40.0% · PAT 20.6%

Return on capital/ 20

15.7

ROCE 31% · ROE 19%

Cash flow quality/ 15

7.9

OCF/EBITDA 68% · FCF yield -0.3%

Leverage discipline/ 10

9.3

Net Debt/EBITDA 0.20x

Reinvestment runway/ 8

7.4

ROCE × retention proxy

Accounting quality/ 7

5.9

OCF conversion proxy

Governance/ 5

3.6

Pledge 0.0% · Risk 28/100

Red flags (1)

− Declining revenueRev 1Y -12.9%-4

✓ Computed from real Trendlyne annuals (revenue, EBITDA, PAT, OCF, equity).

Technical score (TQ-100)

80/ 100A

Computed from real 1Y OHLCV pulled from NSE direct: trend, momentum, volume, RS vs Nifty, MA cluster, mean reversion, volatility, patterns minus red flags.

Base 80

Trend structure/ 20

19.0

Above 200DMA · -12% from 52W high

Momentum velocity/ 15

15.0

RSI(14) 56 · 1M 4.0%

Volume dynamics/ 15

6.0

Bucket: Micro Cap

Relative strength/ 15

9.5

RS vs Nifty 8%

MA cluster/ 10

10.0

200DMA + 1Y trend confirmation

Mean-reversion runway/ 10

9.7

RSI(14) 56; ideal 50-60

Volatility profile/ 8

3.6

Bucket: Micro Cap

Pattern integrity/ 7

7.0

Trend continuation proxy

AI research agents

Re-classify segment exposure and re-assess governance risk by running fresh AI agents on the latest data. Results cache to data/agents.json.

Segment classifier

Maps to value-chain segments + computes 0-100 directness

Seed: Specialty Chemicals & Gases · 30/100

Governance assessor

Forensic-accounting flags + 0-100 risk score

Seed: 28/100 risk

AI thesis

Generates a fresh thesis grounded in this company's data. Wires to Anthropic when ANTHROPIC_API_KEY is set, otherwise returns a deterministic mock.

Curated thesis

Analyst-set bull, bear and monitorables · use AI thesis above for a fresh take

Quietly profitable specialty chemicals microcap; semicon optionality is upside, not core thesis.

Bull case

+High ROCE
+Profitable growth
+Diversified portfolio

Bear case

−Liquidity
−Limited disclosure
−Customer concentration

Key monitorables

Revenue mix transparencyMargin sustainabilityCapex trajectory

Semiconductor exposure

How direct, how visible

Primary segment

Specialty Chemicals & Gases

All segments

Specialty Chemicals & Gases

Exposure type

Ancillary

Policy beneficiary

Possible

Import substitution

Medium / Low

Governance risk score

28/100 (lower = better)

Financial snapshot

Latest reported metrics · mock data, ready for live financials

Rev growth (1Y)

-12.9%

Rev CAGR (3Y)

14.5%

EBITDA margin

40.0%

PAT margin

20.6%

ROCE

31%

ROE

19%

OCF / EBITDA

68%

Net Debt / EBITDA

0.2x

Promoter holding

65.0%

Promoter pledge

0.0%

Valuation

P/E (TTM)

30.0

Forward P/E

22.0

EV/EBITDA

21.2

EV/Sales

8.5

P/B

7.8

FCF Yield

-0.3%

Dividend Yield

0.40%

Hist. percentile

55%

Peer percentile

50%

Technicals

RSI(14)

1M return

4.0%

1Y return

24%

From 52W high

-12%

RS vs Nifty

>200 DMA

Yes

Annual financials — real data

Extracted from Trendlyne · audited annuals · TTM + last 6 fiscal years

✓ Real

Line	TTM	FY25	FY24	FY23	FY22	FY21	FY20
Revenue	₹105 cr	₹112 cr	₹129 cr	₹93 cr	₹75 cr	₹51 cr	₹63 cr
↳ YoY growth	-6.7%	-12.9%	+38.1%	+24.7%	+46.3%	-18.2%	—
EBITDA	₹43 cr	₹45 cr	₹26 cr	₹22 cr	₹16 cr	₹15 cr	₹10 cr
↳ EBITDA margin	40.9%	40.0%	20.5%	23.0%	21.0%	29.5%	15.8%
PAT	₹18 cr	₹23 cr	₹28 cr	₹17 cr	₹13 cr	₹10 cr	₹10 cr
↳ PAT margin	17.3%	20.6%	21.8%	18.2%	17.9%	19.1%	15.3%
OCF	₹31 cr	₹31 cr	₹17 cr	₹13 cr	₹3 cr	₹4 cr	₹-6 cr
↳ OCF / EBITDA	71.6%	67.9%	64.4%	62.3%	21.0%	25.8%	-56.6%
FCF (= OCF − capex)	₹-5 cr	₹-3 cr	₹-37 cr	₹2 cr	₹2 cr	₹1 cr	₹-6 cr
Total Equity	₹145 cr	₹122 cr	₹89 cr	₹62 cr	₹50 cr	₹42 cr	₹34 cr
Total Assets	₹192 cr	₹171 cr	₹144 cr	₹77 cr	₹61 cr	₹52 cr	₹41 cr
↳ ROE	12.5%	18.9%	31.6%	27.6%	26.8%	23.3%	28.4%
↳ ROA	9.4%	13.5%	19.5%	22.1%	22.1%	18.7%	23.2%

Source: Trendlyne (Standalone where Consolidated unavailable). Last refresh on real-data ingest.

Promoter pledge & shareholding history

From Trendlyne · 9 quarters · synced Invalid Date

Pledge: 0.0%

Promoter

72.8%

Mutual Funds

0.0%

FII

0.0%

Public

27.2%

Promoter holding trend

69.3

Mar

69.4

Jun

70.5

Sep

72.8

Dec

72.8

Mar

72.8

Jun

72.8

Sep

72.8

Dec

72.8

Mar

Δ:+3.5% over 9 quarters

Commentary

·Promoter INCREASED from 69.3% to 72.8% (rare, positive)
·No pledge
·No institutional holding (smallcap signal)

Management quality

Capital allocation, debt discipline, alignment, governance composite. Computed from disclosed metrics.

Capital allocation

Sustained high return on capital indicates disciplined reinvestment.

ROCE 31%, div yield 0.4%

Promoter holding

Promoter has strong skin in the game.

65.0%

Promoter pledge

No pledging — cleanest signal.

0.0%

Debt discipline

Comfortable leverage band.

Net Debt/EBITDA 0.20x

Cash conversion

Acceptable conversion; track working capital cycles.

OCF/EBITDA 68%

Governance composite

Some watchpoints; nothing disqualifying.

28/100 risk

Variant perception

What the market is pricing in versus our read, and what would invalidate the thesis.

What the market is pricing in

Steady but unspectacular execution. Multiples reflect mid-pack expectations.

What we think it's missing

Consensus appears reasonable. Look for thesis-changing catalysts (margin inflection, new customer wins, segment mix shift) rather than narrative re-rating alone.

Thesis killers

×Working capital blowout disclosed in next quarterly result

References

Wire to live data sources in production

NSE filings Screener BSE corporate filings Annual report (latest)Concall transcript (latest)Investor presentation